Paper28911920
After asthma: redefining airways diseases.
Pavord ID and 22 others. Lancet, 2018. Cited by 846 papers, by iCite.
Cite this record
ConductScience Library. After asthma: redefining airways diseases. Papers, record 28911920. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28911920
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Respiration Disorders | Major topic |
| Humans | |
| Public Health | |
| United Kingdom |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| MR/K002449/2 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| G1000758 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| P01 HL128191 | NHLBI NIH HHS | United States | P01HL128191 | PubMed | NIH RePORTER |
| MR/M016579/1 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| R01 HL080414 | NHLBI NIH HHS | United States | R01HL080414 | PubMed | NIH RePORTER |
| U10 HL109146 | NHLBI NIH HHS | United States | U10HL109146 | PubMed and NIH | NIH RePORTER |
| P01HL107202 | NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05114447 | Severe/Uncontrolled Asthma From General Population to Clinical Setting: Update and Follow-up of the RItA Registry | Background | ClinicalTrials.gov | |
| NCT05870215 | Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma Attacks | Background | ClinicalTrials.gov |
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 28899941 | After the asthmas: Star Wars and Star Trek. | https://conductscience.org/library/papers/28899941 | PubMed |
| Comment in | 28911916 | Transformational thinking about asthma. | https://conductscience.org/library/papers/28911916 | PubMed |
| Comment in | 28911919 | Andrew Bush: a broad portfolio in paediatric respirology. | https://conductscience.org/library/papers/28911919 | PubMed |
Cited by435
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 846 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856588 | Treatable traits-based management of bronchiectasis: moving from theory to clinical practice. | Chin Med J Pulm Crit Care Med | 2026 | https://conductscience.org/library/papers/42856588 | PubMed |
| 42839791 | Asthma: From Phenotypes to Endotypes-Beyond Type 2 Inflammation. | Respirology | 2026 | https://conductscience.org/library/papers/42839791 | PubMed |
| 42782552 | Different Inflammatory Phenotypes and Immune Endotypes Drive Disease Heterogeneity in Asthma and COPD. | Clin Rev Allergy Immunol | 2026 | https://conductscience.org/library/papers/42782552 | PubMed |
| 42724277 | Chronic respiratory morbidity and wheeze after preterm birth: a narrative review. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42724277 | PubMed |
| 42699833 | Preventable Factors in Fatal and Near-Fatal Asthma: Lessons From the British Thoracic Society (BTS) and the National Review of Asthma Deaths (NRAD). | Cureus | 2026 | https://conductscience.org/library/papers/42699833 | PubMed |
| 42645109 | Association Between Serum Leptin Concentrations and Disease Severity Across Airway Disease Phenotypes: A Single-Center Retrospective Observational Study. | Diseases | 2026 | https://conductscience.org/library/papers/42645109 | PubMed |
| 42626115 | Global research landscape and emerging trends of respiratory microbiota and asthma: a bibliometric analysis. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42626115 | PubMed |
| 42624803 | Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies. | Lancet Respir Med | 2026 | https://conductscience.org/library/papers/42624803 | PubMed |
| 42614317 | Mechanism of action of the sinus microbiome in postoperative recurrence of type 2 chronic rhinosinusitis and advances in targeted intervention. | Front Immunol | 2026 | https://conductscience.org/library/papers/42614317 | PubMed |
| 42559162 | Glucocorticoids Impair the Airway Epithelial Barrier via Autophagy-Associated Apoptosis in Asthma: A Preliminary Study Both In Vitro and In Vivo. | Pediatr Discov | 2026 | https://conductscience.org/library/papers/42559162 | PubMed |
| 42548355 | What Sex-Specific Differences Tells Us About Additive vs Synergistic Risk Prediction in Asthma. | CHEST Pulm | 2025 | https://conductscience.org/library/papers/42548355 | PubMed |
| 42514077 | The Gut-Lung Microbiome Axis in Alveolar Stem Cell Regeneration and Lung Repair. | Microorganisms | 2026 | https://conductscience.org/library/papers/42514077 | PubMed |
| 42463269 | It's more than mechanics: the case for metabolic end-points in airways disease. | Eur Respir J | 2026 | https://conductscience.org/library/papers/42463269 | PubMed |
| 42347019 | Nasal Cytology as a Local Biomarker of Airway Inflammation: A Paradigm Shift in Precision Medicine. | Pathophysiology | 2026 | https://conductscience.org/library/papers/42347019 | PubMed |
| 42216027 | Artificial intelligence-based models in predicting acute exacerbations and diagnosing pediatric asthma: a systematic review and meta-analysis. | BMC Med Inform Decis Mak | 2026 | https://conductscience.org/library/papers/42216027 | PubMed |
| 42207418 | Fabrication of Budesonide-Encapsulated β-Glucan Nanoparticles for Alleviation of Acute Bronchial Asthma via Modulation of the p38 MAPK Signaling Pathway. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42207418 | PubMed |
| 42203235 | Validating exacerbations of asthma in electronic health records: a systematic review. | Eur Respir Rev | 2026 | https://conductscience.org/library/papers/42203235 | PubMed |
| 42181872 | Glucocorticoids injure the airway epithelial barrier via endoplasmic reticulum stress-related apoptosis in asthma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42181872 | PubMed |
| 42181267 | Emerging role of SIRT1 in asthma and COPD from molecular mechanisms to translational therapy. | iScience | 2026 | https://conductscience.org/library/papers/42181267 | PubMed |
| 42123938 | The Gut-Lung Axis in Allergic Asthma: A Narrative Review of Microbial Dysbiosis, Immune Regulation, and Nutritional Modulation. | Nutrients | 2026 | https://conductscience.org/library/papers/42123938 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28911920
GET https://conductscience.org/api/papers/v1/28911920/authors?page=2